1. Novel echocardiographic markers for left ventricular filling pressure prediction in heart failure with preserved ejection fraction (ECHO-PREDICT): a prospective cross-sectional study
   Muhammad Suleman et al, 2023, Annals of Medicine & Surgery CrossRef
2. lncRNA TUG1 as potential novel biomarker for prognosis of cardiovascular diseases
   Habib Haybar et al, 2023, Epigenomics CrossRef
3. Prognosticators of All-Cause Mortality in Patients With Heart Failure With Preserved Ejection Fraction
   Jack B. Lopuszynski et al, 2021, The American Journal of Cardiology CrossRef
4. Role of Different Types of miRNAs in Some Cardiovascular Diseases and Therapy-Based miRNA Strategies: A Mini Review
   Safa S. Fayez et al, 2022, BioMed Research International CrossRef
5. Predictive Effect of Triglyceride-Glucose Index on Adverse Prognostic Events in Patients with Type 2 Diabetes Mellitus and Ischemic Cardiomyopathy
   Baiheremujiang Abuduaini et al, 2023, Diabetes, Metabolic Syndrome and Obesity CrossRef
6. Exploration of Potential Genetic Biomarkers for Heart Failure: A Systematic Review
   Sek-Ying Chair et al, 2021, International Journal of Environmental Research and Public Health CrossRef
7. Non-coding RNAs in the pathophysiology of heart failure with preserved ejection fraction
   Elisabeth A. Jalink et al, 2024, Frontiers in Cardiovascular Medicine CrossRef
8. ETS2 promotes cardiomyocyte apoptosis and autophagy in heart failure by regulating lncRNA TUG1/miR‐129‐5p/ATG7 axis
   Li Tan et al, 2023, The FASEB Journal CrossRef
9. ANRIL, H19 and TUG1: a review about critical long non-coding RNAs in cardiovascular diseases
   Lívia da Cunha Agostini et al, 2024, Molecular Biology Reports CrossRef